Who invested in Maxion Therapeutics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

IT Services

Funding summaryUpdated 26 Oct 2026

$91Mraised across 2 rounds since 2023, from 2 sources

$16MRound$75MSeries A

Latest round: Series A, $75MMar 2025
Step-upi: 4.7×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202320242025

$16MRound$75MSeries A

First round: Round, $16M
Biggest round: $75M
Between rounds: 2.1 years

The rounds

Mar 2025
Series A$75M4 new
Source recorded
Feb 2023
Round$16M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

Maxion Therapeutics filed 3 raises, $91M in all. Filings say how much was sold and to how many investors; they never name the investors.

Mar 2025$75MUK share allotment
Feb 2023$16MUK share allotment
Feb 2023$185KUK share allotment

Founders and team

From Maxion Therapeutics's own website: 4 on the team.

Dr Sohaib MirNon-Executive Director
Dr Tim FunnellNon-Executive Director
Elena VibochNon-Executive Director
Eva-Lotta AllanIndependent Chair

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2023Series A2025

Everyone who backed them

General CatalystVC firm1round

Innovate UKVC firm1round

Business Growth FundPrivate equity1round

Eli LillyCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Maxion Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.